Marta Artola Perez de Azanza
Assistant professor
- Name
- Dr. M.E. Artola Perez de Azanza
- Telephone
- +31 71 527 4213
- m.e.artola@lic.leidenuniv.nl
- ORCID iD
- 0000-0002-3051-3902
Human glycosidases and glycosyltransferases are key players in health and disease. The research of Marta combines organic chemistry, chemical biology and medical glycobiology aiming to develop inhibitor libraries and biological tools for glycoprocessing enzymes to find solutions for unmet medical needs in terms of target validation, diagnostics as well as drug development.
More information about Marta Artola Perez de Azanza
PhD candidates
News
Biography
Marta Artola obtained her M.Sc. in Pharmaceutical Sciences in 2008 from Universidad San Pablo CEU in Madrid and after working for a year as research fellow at Janssen-Cilag (Toledo, Spain) she became fascinated by the drug discovery process. In 2009, she moved to Universidad Complutense de Madrid (Spain) where she did her M.Sc. in Organic Chemistry and joined the MedChem Lab to perform her PhD studies under the supervision of Prof. López Rodríguez working on the validation of FtsZ protein as a new therapeutic target for antibacterial drug discovery. During that period she visited Prof. Sieber’s Lab at the Technische Universität München (TUM, Germany) to study the antibacterial activity of her compounds, and later on, she joined Prof. Baran’s group at The Scripps Research Institute in San Diego where she was involved in the total synthesis of Ingenol photoaffinity-based probes. In January 2015 she moved to Leiden University as a postdoctoral researcher under the supervision of Prof. Herman Overkleeft. During her postdoc she developed conformational inhibitors and activity-based probes for diverse glycosidases. Four years later, Marta was appointed as an assistant professor at the Medical Biochemistry Department where, together with her team, combines organic chemistry, chemical biology and biochemistry aiming to develop inhibitor and degrader libraries, activity-based probes and enzymatic substrates for glycoprocessing enzymes that reach solutions for unmet medical needs in terms of target validation, drug discovery and diagnostics.
Curriculum Vitae
Personal information
Nationality: Spanish
Date of birth: 16 January 1985
Education
2010 – 2014 PhD, Medicinal Chemistry Lab, Department of Organic Chemistry, Universidad Complutense de Madrid, Spain (cum laude).
Thesis title: “FtsZ protein as a therapeutic target for the development of new antibacterial agents”.
Advisors: Prof. María Luz López Rodríguez, Dr. Henar Vázquez Villa, Dr. María del Mar Martín-Fontecha
2009 – 2010 MSc in Organic Chemistry, Department of Organic Chemistry, Universidad Complutense de Madrid, Spain.
2003 – 2008 BSc and MSc in Pharmaceutical Sciences, Universidad San Pablo CEU, Madrid, Spain.
Current and previous research positions
2019 – now Tenure Track Assistant Professor, Medical Biochemistry Department, Leiden Institute of Chemistry, Leiden University, The Netherlands
2015 – 2019 Postdoctoral fellow, Bio-organic Synthesis Department, Leiden Institute of Chemistry, Leiden University, The Netherlands
2013 Visiting Researcher at the Prof. Phil Baran’s group, The Scripps Research Institute, La Jolla, CA, USA
2012 Visiting Researcher at the Prof. Spefan Sieber’s group, Technische Universität München, Munich, Germany
2008 – 2009 Junior Research fellow at Janssen-Cilag, Department of Medicinal Chemistry, Toledo, Spain
Grants, awards, recognitions
2023 KIEM grant. “SAILOR: Screening assay for identifying ligands of RNA pseudoknots as new antibacterial and antiviral discovery platform”. Leiden University (10k€)
2023 Marie Skłodowska-Curie Actions Doctoral Networks (MSCA-DN). “GLYCO-N: GLYCOprotein N-glycosylation from non-life to eukaryotes: a Doctoral Network to expand the knowledge on a ubiquitous posttranslational modification of proteins.” Co-applicant (total 2724k€, personal 549k€)
2022 Best abstract award, 7th Fabry Update, Würzburg, Germany “Rational design of pharmacological chaperones for ⍺-Gal A for the treatment of Fabry Disease” (500€)
2022 Leiden Institute of Chemistry competition for a 4-year PhD position. Co-applicant with Dr. Zachary Armstrong. “SWEET-ANTIMICROBIALS: Targeting essential carbohydrate amidases for new antimicrobials” (253k€)
2021 Leiden Institute of Chemistry competition for a 4-year PhD position. Main applicant. “A4GALT Inhibitors and Probes: Seeking Biological Tools to unveil A4GALT Mechanism and Treat Fabry Disease” (250k€)
2021 Leiden Institute of Chemistry competition for a 4-year PhD position. Co-applicant with Prof. Hans Aerts. “Excretion of glycosylated metabolites from the body: occurrence, mechanism and relevance.” (250k€).
2020 Leiden Institute of Chemistry competition for a 4-year PhD position. Co-applicant with Dr. René Olsthoorn. “Knotty business: targeting viral pseudoknots with small drugs” (246k€)
2019 Tenure-track package at Leiden Institute of Chemistry: Permanent Assistant Professor salary and funding for two PhD students
2014 EFMC-Bentham Travel Grant to assist to the EFMC-ISMC XXIII International Symposium on Medicinal Chemistry in Lisbon, Portugal (500€)
2013 Award from Spanish Federation of Medicinal Chemistry (SEQT) for novel researchers (4 best Ph.D. projects in Medicinal chemistry awarded every two years) (2000€)
2010 Ph.D. Full PhD Salary Award: Predoctoral Fellowship (FPU Program) from The Spanish Ministry of Education and Science
Contribution to teaching and supervision
- M.Sc. course Biosynthetic and Pharmaceutical Chemistry (6 ECTS), LIC, Leiden University, The Netherlands
- Lecturer in Pre-University College chemistry lecture series
- M.Sc. course Chemical Biology (6 ECTS), LIC, Leiden University, The Netherlands
- M.Sc. course Molecular Chemistry (6 ECTS), LIC, Leiden University, The Netherlands (2020-2022)
- Teaching staff of practical laboratory techniques in Organic Chemistry, Faculty of Chemistry, Universidad Complutense de Madrid, Spain (2010-2014)
Current supervision of 6 PhD students and co-promotor of 2 graduated PhD students.
Other responsibilities since 2019
- Reviewer for amongst others ACS Chemical Biology, Journal of Organic Chemistry, Chemistry a European Journal, Journal of Bioorganic Chemistry
- Member of the Master Program Committee, LIC, Leiden University
- Founder of the Young Researchers Network within the European Working Group on Gaucher Disease (EWGGD)
Publication record including five recent representative publications
42 papers with >1300 citations, H-index 21 (Google Scholar, 2023)
Full publication record: Google Scholar, Leiden University
- van der Gracht D, Rowland RJ, Roig-Zamboni V, Ferraz MJ, Louwerse M, Geurink PP, Aerts JMFG, Sulzenbacher G, Davies GJ, Overkleeft H, Artola M. Fluorescence Polarisation Activity-Based Protein Profiling for the Identification of Deoxynojirimycin-type Inhibitors selective for Lysosomal Retaining Alpha-and Beta-Glucosidases. Chem. Sci, 2023, 14, 9136–9144. DOI: 10.1039/D3SC01021J
- Kok K, Kuo C-L, Katzy RE, Lelieveld LT, Wu L, Roig-Zamboni V, van der Marel GA, Codée JDC, Sulzenbacher G, Davies GJ, Overkleeft HS, Aerts JMFG, Artola M. 1,6-epi-Cyclophellitol Cyclosulfamidate Is a Bona Fide Lysosomal α-Glucosidase Stabilizer for the Treatment of Pompe Disease. J. Am. Chem. Soc. 2022, 144 (32): 14819–14827. DOI: 10.1021/jacs.2c05666
- Artola, M.; Hedberg, C.; Rowland, R. J.; Raich, L.; Kytidou, K., Wu, L.; Schaaf, A.; Ferraz, M. J., Van Der Marel, G. A., Codée, J. D. C., Aerts JMFG, Davies GJ, Overkleeft HS. α-d-Gal-Cyclophellitol Cyclosulfamidate Is a Michaelis Complex Analog That Stabilizes Therapeutic Lysosomal α-Galactosidase A in Fabry Disease. Chem. Sci. 2019, 10 (40), 9233–9243. DOI: 10.1039/C9SC03342D
- Artola M, Kuo CL, Lelieveld LT, Rowland RJ, van der Marel GA, Codée JDC, Boot RG, Davies GJ, Aerts JMFG, Overkleeft HS. Functionalized Cyclophellitols Are Selective Glucocerebrosidase Inhibitors and Induce a Bona Fide Neuropathic Gaucher Model in Zebrafish. J. Am. Chem. Soc. 2019, 141 (10): 4214–4218. DOI: 10.1021/jacs.9b00056
- Kuo CL, Kallemeijn WW, Lelieveld LT, Mirzaian M, Zoutendijk I, Vardi A, Futerman AH, Meijer AH, Spaink HP, Overkleeft HS, Aerts JMFG, Artola M. In vivo inactivation of glycosidases by conduritol B epoxide and cyclophellitol as revealed by activity‐based protein profiling. The FEBS Journal 2019, 286, 584–600. DOI: 10.1111/febs.14744
- Artola M, Wu L, Ferraz MJ, Kuo CL, Raich L, Breen IZ, Offen WA, Codée JDC, van der Marel GA, Rovira C, Aerts JMFG, Davies GJ, Overkleeft HS. 1,6-Cyclophellitol Cyclosulfates: A New Class of Irreversible Glycosidase Inhibitor. ACS Cent. Sci. 2017, 3 (7): 784–793. DOI: 10.1021/acscentsci.7b00214
Assistant professor
- Science
- Leiden Institute of Chemistry
- LIC/Chemical Biology
- Ofman T.P., Heming J.J.A., Nin-Hill A., Küllmer F., Moran E., Bennett M., Steneker R., Klein A.M., Ruijgrok G., Kok K., Armstrong Z.W.B., Aerts J.M.F.G., Marel G.A. van der, Rovira C., Davies G.J., Artola M.E., Codée J.D.C. & Overkleeft H.S. Rovira Carme Davies Gideon J. Artola Marta Codée Jeroen D. C. Overkleeft Herman S. (2024), Conformational and electronic variations in 1,2‐ and 1,5a‐Cyclophellitols and their impact on retaining α‐glucosidase inhibition, Chemistry: a European Journal 30(31): e202400723.
- Artola Perez de Azanza M.E., Aerts J.M.F.G., Marel G.A. van der, Rovira C., Codee J.D.C., Davies G.J. & Overkleeft H.S. (2024), From mechanism-based retaining glycosidase inhibitors to activity-based glycosidase profiling, Journal of the American Chemical Society 146(36): 24729-24741.
- Koemans T.S., Bennett M., Guimaraes Da Lomba Ferraz M.J., Armstrong Z.W.B., Artola Perez de Azanza M.E., Aerts J.M.F.G., Codee J.D.C., Overkleeft H.S. & Davies G.J. (2024), Structure-guided design of C3-branched swainsonine as potent and selective human Golgi α-mannosidase (GMII) inhibitor, Chemical Communications : .
- Su Qin Louwerse Max Lammers Rob F. Maurits Elmer Janssen Max Boot Rolf G. Borlandelli Valentina Offen Wendy A. Linzel Daniël Schröder Sybrin P. Davies Gideon J. Overkleeft Herman S. Artola Marta Aerts Johannes M. F. G. (2024), Selective labelling of GBA2 in cells with fluorescent β-D-arabinofuranosyl cyclitol aziridines, Chemical Science 15(37): 15212-15220.
- Bannink S., Bila K.O., Weperen J. van, Ligthart N.A.M., Ferraz M.J., Boot R.G., Vliet D. van der, Boer D.E.C., Overkleeft H.S., Artola M. & Aerts J.M.F.G. (2024), 6-O-alkyl 4-methylumbelliferyl-β-D-glucosides as selective substrates for GBA1 in the discovery of glycosylated sterols, Journal of Lipid Research 65(11): 100670.
- Thaler M., Ofman T.P., Kok K., Heming J.J.A., Moran E., Pickles I., Leijs A.A., Nieuwendijk A.M.C.H. van den, Berg R.J.B.H.N. van den, Ruijgrok G., Armstrong Z., Salgado-Benvindo C., Ninaber D.K., Snijder E.J., Boeckel C.A.A. van, Artola M., Davies G.J., Overkleeft H.S. & Hemert M.J. van (2024), Epi-Cyclophellitol Cyclosulfate, a Mechanism-Based Endoplasmic Reticulum α-Glucosidase II Inhibitor, Blocks Replication of SARS-CoV-2 and Other Coronaviruses, ACS Central Science 10(8): 1594-1608.
- Radchenko Y., Su Q., Schroder S.S., Gijlswijk L. van, Artola M., Aerts J.M.F.G., Codee J.D.C. & Overkleeft H.S. (2024), Synthesis and Biological Evaluation of Deoxycyclophellitols as Human Retaining β-Glucosidase Inhibitors, Chemistry: a European Journal 30(70): e202402988.
- Gracht D. van der, Rowland R.J., Roig-Zamboni V., Guimaraes Da Lomba Ferraz M.J., Louwerse G.A.M., Geurink P.P., Aerts J.M.F.G., Sulzenbacher G., Davies G.J., Overkleeft H.S. & Artola Perez de Azanza M.E. (2023), Fluorescence polarisation activity-based protein profiling for the identification of deoxynojirimycin-type inhibitors selective for lysosomal retaining alpha- and beta-glucosidases, Chemical Science 14(34): 9136-9144.
- Males A., Kok K., Nin-Hill A., Koster N. de, Beukel S. van den, Beenakker T.J.M., Marel G.A. van der, Codée J.D.C., Aerts J.M.F.G., Overkleeft H.S., Rovira C., Davies G. & Artola Perez de Azanza M.E. (2023), Trans-cyclosulfamidate mannose-configured cyclitol allows isoform-dependent inhibition of GH47 α-d-mannosidases through a bump–hole strategy, Chemical Science 14(46): 13581-13586.
- Borlandelli V.B., Offen W., Moroz O., Nin-Hill A., Mcgregor N., Binkhorst L., Ishiwata A., Armstrong Z., Artola Perez de Azanza M.E., Rovira C., Davies G.J. & Overkleeft H.S. (2023), β-l-arabinofurano-cyclitol aziridines are covalent broad-spectrum inhibitors and activity-based probes for retaining β-l-arabinofuranosidases, ACS Chemical Biology 18(12): 2564-2573.
- Borlandelli V., Armstrong Z., Nin-Hill A., Codée J., Raich L., Artola M., Rovira C., Davies G. & Overkleeft H.S. (2023), 4-O-substituted glucuronic cyclophellitols are selective mechanism-based heparanase inhibitors, ChemMedChem 18(4): e202200580.
- Su Q., Schroder S.P., Lelieveld L.T., Guimaraes Da Lomba Ferraz M.J., Verhoek M., Boot R.G., Overkleeft H.S., Aerts J.M.F.G., Artola Perez de Azanza M.E. & Kuo C.L. (2023), Corrigendum: Xylose-configured cyclophellitols as selective inhibitors for glucocerebrosidase, ChemBioChem 24(3): e202300728.
- Lelieveld L.T., Gerhardt S., Maas S., Zwiers K.C., Wit C. de, Beijk E.H., Guimaraes Da Lomba Ferraz M.J., Artola Perez de Azanza M.E., Meijer A.H., Tudorache C., Salvatori D., Boot R.G. & Aerts J.M.F.G. (2022), Consequences of excessive glucosylsphingosine in glucocerebrosidase-deficient zebrafish, Journal of Lipid Research 63(5): 100199.
- Kok K., Kuo C.L., Katzy R.E., Lelieveld L.T., Wu L., Roig-Zamboni V., Marel G.A. van der, Codee J.D.C., Sulzenbacher G., Davies G.J., Overkleeft H.S., Aerts J.M.F.G. & Artola Perez de Azanza M.E. (2022), 1,6-epi-Cyclophellitol cyclosulfamidate is a bona fide lysosomal α-glucosidase stabilizer for the treatment of Pompe disease, Journal of the American Chemical Society 144(32): 14819-14827.
- Chen Y., Armstrong Z., Artola M., Florea B.I., Kuo C.L., Boer C. de, Rasmussen M.S., Abou Hachem M., Marel G.A. van der, Codee J.D.C., Aerts J.M.F.G., Davies G.J. & Overkleeft H.S. (2021), Activity-based protein profiling of retaining alpha-amylases in complex biological samples, Journal of the American Chemical Society 143(5): 2423-2432.
- McGregor N.G.S., Coines J., Borlandelli V.B., Amaki S., Artola M., Nin-Hill A., Linzel D., Yamada C., Arakawa T., Ishiwata A., Ito Y., Marel G.A. van der, Codee J.D.C., Fushinobu S., Overkleeft H.S., Rovira C. & Davies G.J. (2021), Cysteine nucleophiles in glycosidase catalysis: application of a covalent β‐l‐arabinofuranosidase inhibitor, Angewandte Chemie (International Edition) 60(11): 5754-5758.
- Kok K., Zwiers K.C., Boot R.G., Overkleeft H.S., Aerts J.M.F.G. & Artola M. (2021), Fabry disease: molecular basis, pathophysiology, diagnostics and potential therapeutic directions, Biomolecules 11(2): 271.
- Boer D.E., Mirzaian M., Ferraz M.J., Zwiers K.C., Baks M.V., Hazeu M.D., Ottenhoff R., Marques A.R.A., Meijer R., Roos J.C.P., Cox T.M., Boot R.G., Pannu N., Overkleeft H.S., Artola M. & Aerts J.M.F.G. (2021), Human glucocerebrosidase mediates formation of xylosyl-cholesterol by beta-xylosidase and transxylosidase reactions, Journal of Lipid Research 62: 100018.
- Su Q., Schröder S.P., Lelieveld L.T., Ferraz M.J., Verhoek M., Boot R.G., Overkleeft H.S., Aerts J.M.F.G., Artola M. & Kuo C.L. (2021), Xylose-configured cyclophellitols as selective inhibitors for glucocerebrosidase, ChemBioChem 22(21): 3090-3098.
- Rowland R.J., Chen Y., Breen I., Wu L., Offen W.A., Beenakker T.J.M., Su Q., Nieuwendijk A.M.C.H. van den, Aerts J.M.F.G., Artola Perez de Azanza M.E., Overkleeft H.S. & Davies G.J. (2021), Design, Synthesis and Structural Analysis of Glucocerebrosidase Imaging Agents, Chemistry: a European Journal 27: 1-13.
- Huecas S., Araujo-Bazan L., Ruiz F.M., Ruiz-Avila L.B., Martinez R.F., Escobar-Pena A., Artola Perez de Azanza M.E., Vazquez-Villa H., Martin-Fontecha M., Fernandez-Tornero C., Lopez-Rodriguez M.L. & Andreu J.M. (2021), Targeting the FtsZ allosteric binding site with a novel fluorescence polarization screen, cytological and structural approaches for antibacterial discovery, Journal of Medicinal Chemistry 64(9): 5730-5745.
- McGregor N.G.S., Artola M., Nin-Hill A., Linzel D., Haon M., Reijngoud J., Ram A., Rosso M.N., Marel G.A. van der, Codée J.D.C., Wezel G.P. van, Berrin J.G., Rovira C., Overkleeft H.S. & Davies G.J. (2020), Rational Design of Mechanism-Based Inhibitors and Activity-Based Probes for the Identification of Retaining α-l-Arabinofuranosidases, Journal of the American Chemical Society 142(10): 4648-4662.
- Kytidou K., Artola M., Overkleeft H.S. & Aerts J.M.F.G. (2020), Plant Glycosides and Glycosidases: A Treasure-Trove for Therapeutics, Frontiers in Plant Science 11: 357.
- Boer D.E.C., Mirzaian M., Ferraz M.J., Zwiers K.C., Baks M.V., Hazeu M.D., Ottenhoff R., Marques A.R.A., Meijer R., Roos J.P.C., Cox T.M., Boot R.G., Pannu N., Overkleeft H.S., Artola M. & Aerts J.M.F.G. (2020), Human glucocerebrosidase mediates formation of xylosyl-cholesterol by β-xylosidase and transxylosidase reactions, Journal of Lipid Research 61(12): jlr.RA120001043.
- McGregor N.G.S., Turkenburg J.P., Krogh K.B.R.M., Nielsen J.E., Artola M., Stubbs K.A., Overkleeft H.S. & Davies G.J. (2020), Structure of a GH51 α-L-arabinofuranosidase from Meripilus giganteus: conserved substrate recognition from bacteria to fungi, Acta Crystallographica Section D Structural Biology 76(11): 1124-1133.
- Artola M., Kuo C.L., Lelieveld L.T., Rowland R.J., Marel G.A. van der, Codée J.D.C., Boot R.G., Davies G.J., Aerts J.M.F.G. & Overkleeft H.S. (2019), Functionalized cyclophellitols are selective glucocerebrosidase inhibitors and induce a bona fide neuropathic Gaucher model in zebrafish, Journal of the American Chemical Society 141(10): 4214-4218.
- Wu L., Armstrong Z., Schröder S.P., Boer C. de, Artola M., Aerts J.M.F.G., Overkleeft H.S. & Davies G.J. (2019), An overview of activity-based probes for glycosidases, Current Opinion in Chemical Biology 53: 25-36.
- Lelieveld L.T., Mirzaian M., Kuo C.L., Artola Perez de Azanza M.E., Guimaraes da Lomba Ferraz M.J., Peter R.E.A., Akiyama H., Greimel P., Berg R.J.B.H.N. van den, Overkleeft H.S., Boot R.G., Meijer A. & Aerts J.M.F.G. (2019), Role of β-glucosidase 2 in aberrant glycosphingolipid metabolism: model of glucocerebrosidase deficiency in zebrafish, Journal of Lipid Research 60(11): 1851-1867.
- Artola M., Hedberg C., Rowland R.J., Raich L., Kytidou K., Wu L., Schaaf A., Ferraz M.J., Marel G.A. van der, Codee J.D.C., Rovira C., Aerts J.M.F.G., Davies G.J. & Overkleeft H.S. (2019), Alpha-d-Gal-cyclophellitol cyclosulfamidate is a Michaelis complex analog that stabilizes therapeutic lysosomal alpha-galactosidase A in Fabry disease, Chemical Science 10(40): 9233-9243.
- Jariwala P.B., Pellock S.J., Goldfarb D., Cloer E.W., Artola M., Simpson J.B., Bhatt A.P., Walton W.G., Roberts L.R., Major M.B., Davies G.J., Overkleeft H.S. & Redinbo M.R. (2019), Discovering the Microbial Enzymes Driving Drug Toxicity with Activity-Based Protein Profiling, ACS Chemical Biology 15(1): 217-225.
- Kuo C.L., Kallemeijn W.W., Lelieveld L.T., Mirzaian M., Zoutendijk I., Vardi A., Futerman A.H., Meijer A.H., Spaink H.P., Overkleeft H.S., Aerts J.M.F.G. & Artola Perez de Azanza M.E. (2019), In vivo inactivation of glycosidases by conduritol B epoxide and cyclophellitol as revealed by activity‐based protein profiling, FEBS Journal 286(3): 584-600.
- Aerts J.M.F.G., Artola M.E., Eijk M.C. van, Ferraz M.J. & Boot R.G. (2019), Glycosphingolipids and infection. Potential new therapeutic avenues, Frontiers in Cell and Developmental Biology 7: 324.
- Kuo C.L., Kallemeijn W.W., Lelieveld L.T., Mirzaian M., Zoutendijk I., Vardi A., Futerman A.H., Meijer A.H., Spaink H.P., Overkleeft H.S., Aerts J.M.F.G. & Artola M. (2019), In vivo inactivation of glycosidases by conduritol B epoxide and cyclophellitol as revealed by activity-based protein profiling, FEBS Journal 286(3): 584-600.
- Artola Perez de Azanza M.E., Wouters S., Schröder S.P., Boer C. de, Chen Y., Petracca R., Nieuwendijk A.M.C.H. van den, Aerts J.M.F.G., Marel G.A. van der, Codée J.D.C. & Overkleeft H.S. (2019), Direct Stereoselective Aziridination of Cyclohexenols with 3-Amino-2-(trifluoromethyl)quinazolin-4(3H)-one in the Synthesis of Cyclitol Aziridine Glycosidase Inhibitors, European Journal of Organic Chemistry 2019(6): 1397-1404.
- Kuo C.L., Meel H.M.M. van, Kytidou K., Kallemeijn W.W., Witte M., Overkleeft H.S., Artola Pérez de Azanza M.E. & Aerts J.M.F.G. (2018), Activity-Based Probes for Glycosidases: Profiling and Other Applications. In: Imperiali B. (Ed.), Chemical Glycobiology Part B. Monitoring Glycans and their Interactions. Methods in Enzymology no. 598: Elsevier: Monograph Series. 217-235.
- Schröder S.P., Wu L., Artola Perez de Azanza M.E., Hansen T., Offen W.A., Guimaraes da Lomba Ferraz M.J., Li K.-Y., Aerts J.M.F.G., Marel G.A. van der, Codee J.D.C., Davies G.J. & Overkleeft H.S. (2018), Gluco-1H-imidazole: A New Class of Azole-Type beta-Glucosidase Inhibitor, Journal of the American Chemical Society 140(15): 5045-5048.
- Ben Bdira F., Artola Perez de Azana M.E., Overkleeft H.S., Ubbink M. & Aerts J.M.F.G. (2018), Distinguishing the differences in beta-glycosylceramidase folds, dynamics, and actions informs therapeutic uses, Journal of Lipids 59(12): 2262-2276.
- Kytidou K., Beekwilder J., Artola M., Meel E. van, Wilbers R.H.P., Moolenaar G.F., Goosen N., Ferraz M.J., Katzy R., Voskamp P., Florea B.I., Hokke C.H., Overkleeft H.S., Schots A., Bosch D., Pannu N. & Aerts J.M.F.G. (2018), Nicotiana benthamiana α-galactosidase A1.1 can functionally complement human α-galactosidase A deficiency associated with Fabry disease, Journal of Biological Chemistry 293(26): 10042-10058.
- Artola M., Kuo C.L., McMahon S.A., Oehler V., Hansen T., Lienden M.J.C. van der, He X., Elst H. van den, Florea B.I., Kermode A.R., Marel G.A. van der, Gloster T.M., Codée J.D.C., Overkleeft H.S. & Aerts J.M.F.G. (2018), New Irreversible alpha-l-Iduronidase Inhibitors and Activity-Based Probes, Chemistry: a European Journal 24(71): 19081-19088.
- Breen I.Z., Artola Perez de Azanza M.E., Wu L., Beenakker T.J.M., Offen W.A., Aerts J.M.F.G., Davies G.J. & Overkleeft H.S. (2018), Competitive and covalent inhibitors of human lysosomal retaining exoglucosidases. In: Maccarrone M. (Ed.), eLS: Wiley Online Library.
- Petracca R., Romeo E., Baggelaar M.P., Artola M., Pontis S., Ponzano S., Overkleeft H.S., Stelt M. van der & Piomelli D. (2017), Novel activity-based probes for N-acylethanolamine acid amidase, Chemical Communications 53(86): 11810-11813.
- Artola Perez de Azanza M.E., Wu L., Guimaraes da Lomba Ferraz M.J., Kuo C.L., Raich L., Breen I.Z., Offen W.A., Codee J.D.C., Marel G.A. van der, Rovira C., Aerts J.M.F.G., Davies G.J. & Overkleeft H.S. (2017), 1,6-Cyclophellitol Cyclosulfates: A New Class of Irreversible Glycosidase Inhibitor, ACS Central Science 3(7): 784-793.
- Wu L., Jiang J., Jin Y., Kallemeijn W.W., Kuo C.-L., Artola M., Dai W., Elk C. van, Eijk M. van, Marel G.A. van der, Codee J.D.C., Florea B.I., Aerts J.M.F.G., Overkleeft H.S. & Davies G.J. (2017), Activity-based probes for functional interrogation of retaining beta-glucuronidases, Nature Chemical Biology 13(8): 867-873.
- Beenakker T.J.M., Wander D.P.A., Offen W.A., Artola Perez de Azanza M.E., Raich L., Guimaraes da Lomba Ferraz M.J., Li K.Y., Houben J.H.P.M., Rijssel E.R. van, Hansen T., Marel G.A. van der, Codee J.D.C., Aerts J.M.F.G., Rovira C., Davies G.J. & Overkleeft H.S. (2017), Carba-cyclophellitols Are Neutral Retaining-Glucosidase Inhibitors, Journal of the American Chemical Society 139(19): 6534-6537.
- Schröder S.P., Sande J.W. van de, Kallemeijn W.W., Kuo C.L., Artola Perez de Azanza M.E., Rooden E.J. van, Jiang J., Beenakker T.J.M., Florea B.I., Offen W.A., Davies G.J., Minnaard A.J., Aerts J.M.F.G., Codee J.D.C., Marel G.A. van der & Overkleeft H.S. (2017), Towards broad spectrum activity-based glycosidase probes: synthesis and evaluation of deoxygenated cyclophellitol aziridines, Chemical Communications 53(93): 12528-12531.
- Parker C.G., Kuttruff C.A., Galmozzi A., Jorgensen L., Yeh C.-H., Hermanson D.J., Wang Y., Artola M., McKerrall S.J., Josyln C.M., Norremark B., Dunstl G., Felding J., Saez E., Baran P.S. & Cravatt B.F. (2017), Chemical Proteomics Identifies SLC25A20 as a Functional Target of the Ingenol Class of Actinic Keratosis Drugs, ACS Central Science 3(12): 1276-1285.
- Artola M., Ruiz-Avila L.B., Ramirez-Aportela E., Fernando Martinez R., Araujo-Bazan L., Vazquez-Villa H., Martin-Fontecha M., Oliva M.A., Martin-Galiano A.J., Chacon P., Lopez-Rodriguez M.L., Andreu J.M. & Huecas S. (2017), The structural assembly switch of cell division protein FtsZ probed with fluorescent allosteric inhibitors, Chemical Science 8(2): 1525-1534.
- Jiang J., Artola Perez de Azanza M.E., Beenakker T.J.M., Schröder S.P., Petracca R., Boer C. de, Aerts J.M.F.G., Marel G.A. van der, Codée J.D.C. & Overkleeft H.S. (2016), The synthesis of cyclophellitol-aziridine and its configurational and functional isomers, European Journal of Organic Chemistry 2016(22): 3671-3678.
- Schroder S., Petracca R., Minnee H., Artola M., Aerts J.M.F.G., Codée J.D.C., Marel G.A. van der & Overkleeft H.S. (2016), A Divergent Synthesis of L-arabino- and D-xylo-configured Cyclophellitol Epoxides and Aziridines, European Journal of Organic Chemistry : .
- Artola Perez de Azanza M., Ruiz-Avila L.B., Vergonos A., Huecas S., Araujo-Bazan L., Martin-Fontecha M., Vazquez-Villa H., Turrado C., Ramirez-Aportela E., Hoegl A., Nodwell M., Barasoain I., Chacon P., Sieber S.A., Andreu J.M. & Lopez-Rodriguez M.L. (2015), Effective GTP-Replacing FtsZ Inhibitors and Antibacterial Mechanism of Action, ACS Chemical Biology 10(3): 834-843.
- Bartolome-Nebreda J.M., Alonso de Diego S.A., Artola M., Delgado F., Delgado O., Luz Martin-Martin M., Martinez-Viturro C.M., Ángel Pena M., Min Tong H., Gool M. van, Manuel Alonso J., Fontana A., Macdonald G.J., Megens A., Langlois X., Somers M., Vanhoof G. & Conde-Ceide S. (2015), Identification of a Novel Orally Bioavailable Phosphodiesterase 10A (PDE10A) Inhibitor with Efficacy in Animal Models of Schizophrenia, Journal of Medicinal Chemistry 58(2): 978-993.
- Perez-Gomez E., Andradas C., Blasco-Benito S., Caffarel M.M., Garcia-Taboada E., Villa-Morales M., Moreno E., Hamann S., Martin-Villar E., Flores J.M., Wenners A., Alkatout I., Klapper W., Roecken C., Bronsert P., Stickeler E., Staebler A., Bauer M., Arnold N., Soriano J., Perez-Martinez M., Megias D., Moreno-Bueno G., Ortega-Gutierrez S., Artola M., Vazquez-Villa H., Quintanilla M., Fernandez-Piqueras J., Canela E.I., McCormick P.J., Guzman M. & Sanchez C. (2015), Role of Cannabinoid Receptor CB2 in HER2 Pro-oncogenic Signaling in Breast Cancer, Journal of the National Cancer Institute 107(6): djv077.
- Ruiz-Ayila L.B., Huecas S., Artola M., Vergonos A., Ramirez-Aportela E., Cercenado E., Barasoain I., Vazquez-Villa H., Martin-Fontecha M., Chacon P., Lopez-Rodriguez M.L. & Andreu J.M. (2013), Synthetic Inhibitors of Bacterial Cell Division Targeting the GTP-Binding Site of FtsZ, ACS Chemical Biology 8(9): 2072-2083.
- Turrado C., Puig T., Garcia-Carceles J., Artola Perez de Azanza M., Benhamu B., Ortega-Gutierrez S., Relat J., Oliveras G., Blancafort A., Haro D., Marrero P.F., Colomer R. & Lopez-Rodriguez M.L. (2012), New Synthetic Inhibitors of Fatty Acid Synthase with Anticancer Activity, Journal of Medicinal Chemistry 55(11): 5013-5023.